Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors

被引:18
作者
Gonzalez-Murillo, Africa [1 ,2 ]
Lozano, M. Luz [1 ,2 ]
Montini, Eugenio [3 ]
Bueren, Juan A. [1 ,2 ]
Guenechea, Guillermo [1 ,2 ]
机构
[1] CIEMAT, Hematopoiesis & Gene Therapy Div, E-28040 Madrid, Spain
[2] CIBERER, Madrid, Spain
[3] Univ Milan, Osped San Raffaele, HSR TIGET, I-20127 Milan, Italy
关键词
D O I
10.1182/blood-2008-03-142661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies of retroviral-mediated gene transfer have shown that retroviral integrations themselves may trigger nonmalignant clonal expansion of hematopoietic stem cells (HSCs) in transplant recipients. These observations suggested that previous conclusions of HSC dynamics based on gamma-retroviral gene marking should be confirmed with improved vectors having a more limited capacity to transactivate endogenous genes. Because of the low trans-activation activity of self-inactivating lentiviral vectors (LVs), we have investigated whether the LV marking of mouse HSCs induces a competitive repopulation advantage in recipients of serially transplants. As deduced from analyses conducted in primary and secondary recipients, we concluded that lentivirally transduced HSCs have no competitive repopulation advantages over untransduced HSCs. By linear amplification-mediated polymerase chain reaction (LAM-PCR) analysis, we characterized LV-targeted genes in HSC clones that engrafted up to quaternary recipients. Although 9 clones harbored integrations close to defined retroviral insertion sites, none was characterized as a common integration site, and none was present in HSC clones repopulating quaternary recipients. Taken together, our results show unaltered repopulation properties of HSCs transduced with LVs, and confirm early studies suggesting the natural capacity of a few HSC clones to generate a monoclonal or oligoclonal hematopoiesis in transplant recipients.
引用
收藏
页码:3138 / 3147
页数:10
相关论文
共 55 条
[21]   LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 [J].
Hacein-Bey-Abina, S ;
Von Kalle, C ;
Schmidt, M ;
McCcormack, MP ;
Wulffraat, N ;
Leboulch, P ;
Lim, A ;
Osborne, CS ;
Pawliuk, R ;
Morillon, E ;
Sorensen, R ;
Forster, A ;
Fraser, P ;
Cohen, JI ;
de Saint Basile, G ;
Alexander, I ;
Wintergerst, U ;
Frebourg, T ;
Aurias, A ;
Stoppa-Lyonnet, D ;
Romana, S ;
Radford-Weiss, I ;
Gross, F ;
Valensi, F ;
Delabesse, E ;
Macintyre, E ;
Sigaux, F ;
Soulier, J ;
Leiva, LE ;
Wissler, M ;
Prinz, C ;
Rabbitts, TH ;
Le Deist, F ;
Fischer, A ;
Cavazzana-Calvo, M .
SCIENCE, 2003, 302 (5644) :415-419
[22]   A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency [J].
Hacein-Bey-Abina, S ;
von Kalle, C ;
Schmidt, M ;
Le Deist, F ;
Wulffraat, N ;
McIntyre, E ;
Radford, I ;
Villeval, JL ;
Fraser, CC ;
Cavazzana-Calvo, M ;
Fischer, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03) :255-256
[23]   Globin lentiviral vector insertions can perturb the expression of endogenous genes in β-thalassemic hematopoietic cells [J].
Hargrove, Phillip W. ;
Kepes, Steven ;
Hanawa, Hideki ;
Obenauer, John C. ;
Pei, Deiqing ;
Cheng, Cheng ;
Gray, John T. ;
Neale, Geoffrey ;
Persons, Derek A. .
MOLECULAR THERAPY, 2008, 16 (03) :525-533
[24]   High-level β-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells [J].
Imren, S ;
Fabry, ME ;
Westerman, KA ;
Pawliuk, R ;
Tang, P ;
Rosten, PM ;
Nagel, RL ;
Leboulch, P ;
Eaves, CJ ;
Humphries, RK .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (07) :953-962
[25]   CLONAL AND SYSTEMIC ANALYSIS OF LONG-TERM HEMATOPOIESIS IN THE MOUSE [J].
JORDAN, CT ;
LEMISCHKA, IR .
GENES & DEVELOPMENT, 1990, 4 (02) :220-232
[26]   Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny [J].
Klug, CA ;
Cheshier, S ;
Weissman, IL .
BLOOD, 2000, 96 (03) :894-901
[27]   Kinetics of fluorescence expression in nonhuman primates transplanted with GFP retrovirus-modified CD34 cells [J].
Kurre, P ;
Morris, J ;
Andrews, RG ;
Kohn, DB ;
Kiem, HP .
MOLECULAR THERAPY, 2002, 6 (01) :83-90
[28]   Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking [J].
Kustikova, O ;
Fehse, B ;
Modlich, U ;
Yang, M ;
Düllmann, J ;
Kamino, K ;
von Neuhoff, N ;
Schlegelberger, B ;
Li, ZX ;
Baum, C .
SCIENCE, 2005, 308 (5725) :1171-1174
[29]   Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways [J].
Kustikova, Olga S. ;
Geiger, Hartmut ;
Li, Zhixiong ;
Brugman, Martijn H. ;
Chambers, Stuart M. ;
Shaw, Chad A. ;
Pike-Overzet, Karin ;
de Ridder, Dick ;
Staal, Frank J. T. ;
von Keudell, Gottfried ;
Cornils, Kerstin ;
Nattamai, Kalpana Jekumar ;
Modlich, Ute ;
Wagemaker, Gerard ;
Goodell, Margaret A. ;
Fehse, Boris ;
Baum, Christopher .
BLOOD, 2007, 109 (05) :1897-1907
[30]   Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns [J].
Laufs, S ;
Nagy, KZ ;
Giordano, FA ;
Hotz-Wagenblatt, A ;
Zeller, WJ ;
Fruehauf, S .
MOLECULAR THERAPY, 2004, 10 (05) :874-881